AtriCure, Inc. (ATRC)
27.30
+0.38
(+1.43%)
USD |
NASDAQ |
Jun 09, 16:00
27.30
0.00 (0.00%)
Pre-Market: 20:00
AtriCure SG&A Expense (Quarterly) : 84.55M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Abbott Laboratories | 3.74B |
| Boston Scientific Corp. | 1.781B |
| AngioDynamics, Inc. | 38.16M |
| Alphatec Holdings, Inc. | 137.06M |
| Baxter International, Inc. | 728.00M |